Nuzenio

Tarsus Bets Up

Tarsus Bets Up news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 18:41:00 GMTTarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.com
Fri, 07 Aug 2026 02:02:21 GMTEarnings call transcript: Tarsus beats revenue in Q2 2026, but EPS miss weighs on shares - Investing.com Canada
Thu, 06 Aug 2026 20:43:00 GMTTarsus Bets Up To $800M On Alkeus In Retina Therapy Push - Law360
Thu, 06 Aug 2026 19:14:51 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive
Thu, 06 Aug 2026 14:08:05 GMTTarsus Adds Alkeus In Up To $800 Million Deal - Finimize
Thu, 06 Aug 2026 12:57:00 GMTTarsus bets $450M on Alkeus’ Stargardt drug - Endpoints News

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tarsus Bets Up.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.